US FDA approves Pfizer’s vaccine for meningococcal disease
Oct 20 (Reuters) – The U.S. Food and Drug Administration (FDA) has approved Pfizer’s (PFE.N) vaccine Penbraya, making it the first shot to protect against five groups of a deadly bacteria that can cause meningitis and blood poisoning, the company said on Friday.
Meningococcal diseases are rare bacterial infections that commonly affect the brain, spinal cord and bloodstream, and can be deadly in a matter of hours.
The pentavalent vaccine protects against five meningococcal bacteria groups – A, B, C, W and Y – which are known to commonly cause the disease.
Read full article: https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-pfizers-vaccine-meningococcal-diseases-2023-10-20/